Dr. Stephen Chanock to Speak on Genome-wide Association Studies in Cancer

BIO:
Dr. Stephen Chanock is a leading expert in the discovery and characterization of cancer susceptibility regions in the human genome. He has received a number of awards for his scientific contributions to our understanding of common inherited genetic variants associated with cancer risk and outcomes.

Dr. Chanock received his M.D. from Harvard Medical School in 1983 and completed clinical training in pediatrics, pediatric infectious diseases, and pediatric hematology/oncology and research training in molecular genetics at Boston Children’s Hospital and the Dana-Farber Cancer Institute, Boston. From 2001-2007, he served as a tenured investigator in the Genomic Variation Section of the Pediatric Oncology Branch in the NCI Center for Cancer Research. Previously, he served as co-chair of NCI's Genetics, Genomics and Proteomics Faculty for five years. In 2001, he was appointed as the Director of the Core Genotyping Facility, and in 2007 as Chief of the newly formed Laboratory of Translational Genomics, both within the intramural Division of Cancer Epidemiology and Genetics program. He has co-led the Cancer Genetic Markers of Susceptibility (CGEMS) project. Session details ...